e6 tcr
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2014 (NCT02280811)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, passive
Human papillomavirus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e6 tcr
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03197025 | Phase 1 | Jul 4, 2017 | National Cancer Institute (NCI) |
| NCT02280811 | Phase 2 | Oct 14, 2014 | National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 2 | 2 | 2014 |
1 organizations
Page 1 / 1